FDA incorporated feedback from the diabetes community in a final guidance document on artificial pancreas systems to allow for more flexibility in the design of clinical trials of the devices.
The Nov. 9 document finalized what had been two distinct draft guidance documents – a December 2011 proposal on clinical...